First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-beta 2),in subjects with open-angle glaucoma undergoing glaucoma filtration surgery

Pfeiffer, Norbert; Voykov, Bogomil; Renieri, Giulia; Bell, Katharina; Richter, Paul; Weigel, Melanie; Thieme, Hagen; Wilhelm, Barbara; Lorenz, Katrin; Feindor, Martin; Wosikowski, Katja; Janicot, Michel; Paeckert, Daniela; Roemmich, Regina; Mala, Carola; Fettes, Petra; Leo, Eugen

dc.contributor.author	Richter, Paul
dc.contributor.author	Wilhelm, Barbara
dc.contributor.author	Voykov, Bogomil Nikolov
dc.date.accessioned	2019-03-27T11:03:06Z
dc.date.available	2019-03-27T11:03:06Z
dc.date.issued	2017
dc.identifier.issn	1932-6203
dc.identifier.uri	http://hdl.handle.net/10900/87272
dc.language.iso	en	de_DE
dc.publisher	Public Library Science	de_DE
dc.relation.uri	http://dx.doi.org/10.1371/journal.pone.0188899	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	500	de_DE
dc.title	First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-beta 2),in subjects with open-angle glaucoma undergoing glaucoma filtration surgery	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190131163842_00368
utue.personen.roh	Pfeiffer, Norbert
utue.personen.roh	Voykov, Bogomil
utue.personen.roh	Renieri, Giulia
utue.personen.roh	Bell, Katharina
utue.personen.roh	Richter, Paul
utue.personen.roh	Weigel, Melanie
utue.personen.roh	Thieme, Hagen
utue.personen.roh	Wilhelm, Barbara
utue.personen.roh	Lorenz, Katrin
utue.personen.roh	Feindor, Martin
utue.personen.roh	Wosikowski, Katja
utue.personen.roh	Janicot, Michel
utue.personen.roh	Paeckert, Daniela
utue.personen.roh	Roemmich, Regina
utue.personen.roh	Mala, Carola
utue.personen.roh	Fettes, Petra
utue.personen.roh	Leo, Eugen
dcterms.isPartOf.ZSTitelID	Plos One	de_DE
dcterms.isPartOf.ZS-Issue	Article e0188899	de_DE
dcterms.isPartOf.ZS-Volume	12	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE